(GTT) Gaztransport & Technigaz SAS - Ratings and Ratios
Cryogenic, Membrane, Storage, Transport, Consulting
Dividends
| Dividend Yield | 4.35% |
| Yield on Cost 5y | 11.18% |
| Yield CAGR 5y | 9.81% |
| Payout Consistency | 93.8% |
| Payout Ratio | 78.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.8% |
| Value at Risk 5%th | 37.1% |
| Relative Tail Risk | -12.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.03 |
| Alpha | 28.55 |
| CAGR/Max DD | 1.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.537 |
| Beta | 0.106 |
| Beta Downside | 0.270 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.67% |
| Mean DD | 7.03% |
| Median DD | 7.15% |
Description: GTT Gaztransport & Technigaz SAS November 06, 2025
Gaztransport & Technigaz (GTT) is a French engineering firm that designs and builds cryogenic membrane containment systems for the maritime transport and storage of liquefied gases, serving ship-owners, gas companies, terminal operators and shipyards worldwide.
It operates two segments: a Core Business focused on LNG and other liquefied-gas solutions-including on-shore storage tanks, floating storage and regasification units (FSRUs), floating storage and unloading units (FLNGs) and floating storage units (FSUs)-and a Hydrogen segment that designs electrolyser-integrated containment for green-hydrogen production and adapts its membranes for LNG-fuelled vessels.
Key industry metrics that drive GTT’s outlook include the projected 7-8 % compound annual growth rate in global LNG demand through 2030, the surge in FSRU deployments (over 30 GW of installed capacity in 2023), and the rapid expansion of the green-hydrogen market, which the International Energy Agency estimates will require roughly 200 GW of electrolyser capacity by 2030.
Financially, GTT reported €525 million of revenue in 2023, with an order backlog of approximately €1.2 billion-equivalent to more than two years of sales-providing visibility into future cash flows, while its operating margin has been pressured by higher material costs and increased R&D spending on hydrogen technologies.
Investors should watch macro-level drivers such as the EU’s Fit-for-55 decarbonisation targets, which incentivise LNG-bunkering and hydrogen adoption, as well as competitive dynamics from emerging membrane-technology rivals in Asia.
For a deeper, data-driven assessment of GTT’s valuation and risk profile, you may find the analytical tools on ValueRay useful.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (645.1m TTM) > 0 and > 6% of Revenue (6% = 76.8m TTM) |
| FCFTA 0.63 (>2.0%) and ΔFCFTA 26.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.24% (prev 37.40%; Δ -8.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.77 (>3.0%) and CFO 660.5m > Net Income 645.1m (YES >=105%, WARN >=100%) |
| Net Debt (-344.6m) to EBITDA (771.4m) ratio: -0.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (37.2m) change vs 12m ago 0.18% (target <= -2.0% for YES) |
| Gross Margin 80.45% (prev 64.30%; Δ 16.16pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 182.7% (prev 103.6%; Δ 79.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8699 (EBITDA TTM 771.4m / Interest Expense TTM 84.0k) >= 6 (WARN >= 3) |
Altman Z'' 14.73
| (A) 0.44 = (Total Current Assets 710.1m - Total Current Liabilities 335.9m) / Total Assets 854.4m |
| (B) 0.58 = Retained Earnings (Balance) 497.6m / Total Assets 854.4m |
| (C) 1.04 = EBIT TTM 730.7m / Avg Total Assets 700.7m |
| (D) 2.81 = Book Value of Equity 995.6m / Total Liabilities 354.0m |
| Total Rating: 14.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 88.93
| 1. Piotroski 8.0pt |
| 2. FCF Yield 8.63% |
| 3. FCF Margin 42.37% |
| 4. Debt/Equity 0.03 |
| 5. Debt/Ebitda -0.45 |
| 6. ROIC - WACC (= 138.6)% |
| 7. RoE 150.2% |
| 8. Rev. Trend 58.03% |
| 9. EPS Trend -4.62% |
What is the price of GTT shares?
Over the past week, the price has changed by +1.05%, over one month by -7.56%, over three months by +10.08% and over the past year by +36.50%.
Is GTT a buy, sell or hold?
What are the forecasts/targets for the GTT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 189 | 9.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 222.1 | 28.7% |
GTT Fundamental Data Overview November 27, 2025
Market Cap EUR = 6.31b (6.31b EUR * 1.0 EUR.EUR)
P/E Trailing = 17.7027
P/E Forward = 17.762
P/S = 8.5844
P/B = 12.6317
Beta = 0.482
Revenue TTM = 1.28b EUR
EBIT TTM = 730.7m EUR
EBITDA TTM = 771.4m EUR
Long Term Debt = 13.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 2.16m EUR (from shortTermDebt, last quarter)
Debt = 15.5m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -344.6m EUR (from netDebt column, last quarter)
Enterprise Value = 6.29b EUR (6.31b + Debt 15.5m - CCE 40.5m)
Interest Coverage Ratio = 8699 (Ebit TTM 730.7m / Interest Expense TTM 84.0k)
FCF Yield = 8.63% (FCF TTM 542.3m / Enterprise Value 6.29b)
FCF Margin = 42.37% (FCF TTM 542.3m / Revenue TTM 1.28b)
Net Margin = 50.40% (Net Income TTM 645.1m / Revenue TTM 1.28b)
Gross Margin = 80.45% ((Revenue TTM 1.28b - Cost of Revenue TTM 250.2m) / Revenue TTM)
Gross Margin QoQ = 70.93% (prev 95.30%)
Tobins Q-Ratio = 7.36 (Enterprise Value 6.29b / Total Assets 854.4m)
Interest Expense / Debt = 0.54% (Interest Expense 84.0k / Debt 15.5m)
Taxrate = 14.76% (31.2m / 211.1m)
NOPAT = 622.8m (EBIT 730.7m * (1 - 14.76%))
Current Ratio = 2.11 (Total Current Assets 710.1m / Total Current Liabilities 335.9m)
Debt / Equity = 0.03 (Debt 15.5m / totalStockholderEquity, last quarter 500.3m)
Debt / EBITDA = -0.45 (Net Debt -344.6m / EBITDA 771.4m)
Debt / FCF = -0.64 (Net Debt -344.6m / FCF TTM 542.3m)
Total Stockholder Equity = 429.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 75.50% (Net Income 645.1m / Total Assets 854.4m)
RoE = 150.2% (Net Income TTM 645.1m / Total Stockholder Equity 429.5m)
RoCE = 165.0% (EBIT 730.7m / Capital Employed (Equity 429.5m + L.T.Debt 13.3m))
RoIC = 145.0% (NOPAT 622.8m / Invested Capital 429.5m)
WACC = 6.40% (E(6.31b)/V(6.33b) * Re(6.41%) + D(15.5m)/V(6.33b) * Rd(0.54%) * (1-Tc(0.15)))
Discount Rate = 6.41% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.02%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈406.8m ; Y1≈501.9m ; Y5≈856.3m
Fair Price DCF = 392.9 (DCF Value 14.56b / Shares Outstanding 37.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -4.62 | EPS CAGR: -74.28% | SUE: 0.0 | # QB: 0
Revenue Correlation: 58.03 | Revenue CAGR: 29.09% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=11.60 | Chg30d=+0.026 | Revisions Net=+1 | Growth EPS=+1.7% | Growth Revenue=-0.8%